74 related articles for article (PubMed ID: 18553282)
21. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K
Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Hamidian Jahromi A; Sangster G; Zibari G; Martin B; Chu Q; Takalkar A; Shi R; Shokouh-Amiri H
JOP; 2013 Jul; 14(4):466-8. PubMed ID: 23846950
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Li XP; Liang Y; Liu X; Wang QS; Wu HB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869
[TBL] [Abstract][Full Text] [Related]
25. [The value of PET-CT imaging in malignant tumours of the head and neck].
Balink H; Krabbe CA; de Visscher JG
Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
[TBL] [Abstract][Full Text] [Related]
26. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Gao S; Li S; Yang X; Tang Q
Oral Oncol; 2014 Mar; 50(3):163-7. PubMed ID: 24368204
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.
Ito K; Yokoyama J; Kubota K; Morooka M
Nucl Med Commun; 2010 Nov; 31(11):931-7. PubMed ID: 20827227
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of squamous cell carcinoma metastasis with 18F-FDG PET/CT in stoma after percutaneous endoscopic gastrostomy: a rare and poorly known iatrogenic cause of spread of head and neck cancer.
de Monès E; Castetbon V; Digue L; Baltazart B; Fernandez P
Clin Nucl Med; 2014 Jun; 39(6):544-6. PubMed ID: 24810782
[TBL] [Abstract][Full Text] [Related]
29. PET/CT in the evaluation of patients with squamous cell cancer of the head and neck.
Goshen E; Davidson T; Yahalom R; Talmi YP; Zwas ST
Int J Oral Maxillofac Surg; 2006 Apr; 35(4):332-6. PubMed ID: 16280234
[TBL] [Abstract][Full Text] [Related]
30. Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas.
Purandare NC; Rangarajan V; Agarwal M; Sharma AR; Shah S; Arora A; Parasar DS
Clin Nucl Med; 2009 Jun; 34(6):350-4. PubMed ID: 19487843
[TBL] [Abstract][Full Text] [Related]
31. Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients.
Senft A; de Bree R; Golding RP; Comans EF; Van Waesberghe JH; Kuik JD; Hoekstra OS; Leemans CR
Mol Imaging Biol; 2011 Apr; 13(2):385-90. PubMed ID: 20533092
[TBL] [Abstract][Full Text] [Related]
32. The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience.
Zimmer LA; Snyderman C; Fukui MB; Blodgett T; McCook B; Townsend DW; Meltzer CC
Ear Nose Throat J; 2005 Feb; 84(2):104, 106, 108-10. PubMed ID: 15794547
[TBL] [Abstract][Full Text] [Related]
33. Atlas of confounding factors in head and neck PET/CT imaging.
Bhargava P; Rahman S; Wendt J
Clin Nucl Med; 2011 May; 36(5):e20-9. PubMed ID: 21467845
[TBL] [Abstract][Full Text] [Related]
34. Head and neck cancer PEG site metastases: Association with PEG placement method.
Montes de Oca MK; Nye A; Porter C; Collins J; Satterfield C; Schammel CMG; Trocha SD
Head Neck; 2019 May; 41(5):1508-1516. PubMed ID: 30614611
[TBL] [Abstract][Full Text] [Related]
35. Combined positron emission tomography/computed tomography for evaluation of presumed choroidal metastases.
Donaldson MJ; Pulido JS; Mullan BP; Inwards DJ; Cantrill H; Johnson MR; Han MK
Clin Exp Ophthalmol; 2006 Dec; 34(9):846-51. PubMed ID: 17181615
[TBL] [Abstract][Full Text] [Related]
36. Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET/CT imaging.
Alhilali L; Reynolds AR; Fakhran S
AJNR Am J Neuroradiol; 2014 Jul; 35(7):1405-11. PubMed ID: 24627451
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later.
Senft A; Hoekstra OS; Castelijns JA; Leemans CR; de Bree R
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3287-91. PubMed ID: 26769038
[TBL] [Abstract][Full Text] [Related]
38. CT-Guided Percutaneous Radiologic Gastrostomy for Patients with Head and Neck Cancer: A Retrospective Evaluation in 177 Patients.
Tamura A; Kato K; Suzuki M; Sone M; Tanaka R; Nakasato T; Ehara S
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):271-8. PubMed ID: 26148649
[TBL] [Abstract][Full Text] [Related]
39. Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography?
Wong WL; Nutting C; Dunn J; Fisher S; MacLennan K; MacCabe C; Mehanna H
Nucl Med Commun; 2009 Jan; 30(1):2-4. PubMed ID: 19306509
[No Abstract] [Full Text] [Related]
40. Long-term percutaneous endoscopic gastrostomy: characteristic computed tomographic findings.
Chang WK; Huang WC; Yu CY; Hsieh TY
Abdom Imaging; 2011 Dec; 36(6):684-8. PubMed ID: 21203756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
